Eyebright Medical Technology Beijing Co Ltd (688050) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, Eyebright Medical Technology Beijing Co Ltd (688050) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥76.92 Million ≈ $11.26 Million USD) by net assets (CN¥3.01 Billion ≈ $440.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Eyebright Medical Technology Beijing Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)

This chart illustrates how Eyebright Medical Technology Beijing Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688050 total liabilities for a breakdown of total debt and financial obligations.

Eyebright Medical Technology Beijing Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Eyebright Medical Technology Beijing Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Telecom Argentina S.A
F:TEO
0.093x
Taiwan Fertilizer Co Ltd
TW:1722
0.023x
Concentrix Corporation
NASDAQ:CNXC
-0.030x
Jiangsu Dagang Co Ltd
SHE:002077
0.016x
Jiangsu Rongtai Industry Co. Ltd.
SHG:605133
0.029x
Huafa Industrial Co Ltd Zhuhai
SHG:600325
0.066x
Uwc Bhd
KLSE:5292
0.030x
FLEX LNG Ltd
OL:FLNG
0.035x

Annual Cash Flow Conversion Efficiency for Eyebright Medical Technology Beijing Co Ltd (2016–2024)

The table below shows the annual cash flow conversion efficiency of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Eyebright Medical Technology Beijing Co .

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 CN¥2.63 Billion
≈ $385.47 Million
CN¥347.75 Million
≈ $50.89 Million
0.132x +37.45%
2023-12-31 CN¥2.36 Billion
≈ $344.75 Million
CN¥226.27 Million
≈ $33.11 Million
0.096x -26.27%
2022-12-31 CN¥1.92 Billion
≈ $280.98 Million
CN¥250.13 Million
≈ $36.60 Million
0.130x +3.37%
2021-12-31 CN¥1.74 Billion
≈ $254.64 Million
CN¥219.30 Million
≈ $32.09 Million
0.126x +58.11%
2020-12-31 CN¥1.55 Billion
≈ $226.47 Million
CN¥123.35 Million
≈ $18.05 Million
0.080x +2.21%
2019-12-31 CN¥647.52 Million
≈ $94.75 Million
CN¥50.49 Million
≈ $7.39 Million
0.078x +35.73%
2018-12-31 CN¥553.87 Million
≈ $81.05 Million
CN¥31.82 Million
≈ $4.66 Million
0.057x +174.70%
2017-12-31 CN¥198.44 Million
≈ $29.04 Million
CN¥4.15 Million
≈ $607.32K
0.021x +216.46%
2016-12-31 CN¥187.52 Million
≈ $27.44 Million
CN¥-3.37 Million
≈ $-492.75K
-0.018x --

About Eyebright Medical Technology Beijing Co Ltd

SHG:688050 China Medical Instruments & Supplies
Market Cap
$1.45 Billion
CN¥9.88 Billion CNY
Market Cap Rank
#7573 Global
#1851 in China
Share Price
CN¥51.11
Change (1 day)
-0.35%
52-Week Range
CN¥49.24 - CN¥82.40
All Time High
CN¥385.84
About

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more